Ruigrok Ynte M, Rinkel Gabriël J E, van't Slot Ruben, Wolfs Marcel, Tang Song, Wijmenga Cisca
Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands.
Hum Mol Genet. 2006 Nov 15;15(22):3361-8. doi: 10.1093/hmg/ddl412. Epub 2006 Oct 12.
Intracranial aneurysm is probably a complex disease with both genetic and non-genetic or environmental risk factors contributing to the etiology of the disease. A disruption of the extracellular matrix (ECM) of the arterial wall is a likely factor in the pathogenesis of intracranial aneurysms. We analyzed 44 potential candidate genes involved in the maintenance of the integrity of the ECM in 382 Dutch Caucasian patients with intracranial aneurysms and 609 Dutch Caucasian controls for 384 tag single nucleotide polymorphisms (SNPs) using the GoldenGate assay on an Illumina BeadStation 500 GX. We identified SNPs that were associated with intracranial aneurysms (P<0.01) in six of these 44 genes: serpine1 (SERPINE1, P=0.0008), transforming growth factor beta induced (TGFBI, P=0.0026), perlecan (HSPG2, P=0.0044), fibronectin (FN1, P=0.0069), fibrillin 2 (FBN2, P=0.0077) and alpha 1 type IV collagen (COL4A1, P=0.0087). In a second independent cohort of 310 Dutch Caucasian intracranial aneurysm patients and 336 Dutch Caucasian controls, the association for the HSPG2 gene [combined odds ratio (OR) 1.33, 95% confidence interval (CI) 1.13-1.57, P=6 x 10(-4)] was replicated. The population attributable risk (PAR) for this SNP is 19%. Combining the two cohorts still showed association for the SERPINE1 (combined OR 1.27, 95% CI 1.07-1.50, P=0.004, PAR 6%), FBN2 (combined OR 1.37, 95% CI 1.07-1.75, P=0.01, PAR 3%) and COL4A1 (combined OR 1.22, 95% CI 1.05-1.42, P=0.007, PAR 7%) genes. These PARs are likely to be overestimates as they are calculated from the joint analyses combining stages 1 and 2 of our association study. Our findings indicate that variation in genes involved in the maintenance of the integrity of the ECM of the arterial wall plays a role in susceptibility to intracranial aneurysms. These findings further support our hypothesis that diminished maintenance of the ECM of the arterial wall is important in the development of intracranial aneurysms.
颅内动脉瘤可能是一种复杂疾病,遗传和非遗传或环境风险因素均对该疾病的病因有影响。动脉壁细胞外基质(ECM)的破坏可能是颅内动脉瘤发病机制中的一个因素。我们使用Illumina BeadStation 500 GX上的GoldenGate检测法,对382名荷兰白人颅内动脉瘤患者和609名荷兰白人对照者中涉及ECM完整性维持的44个潜在候选基因的384个标签单核苷酸多态性(SNP)进行了分析。我们在这44个基因中的6个基因中鉴定出与颅内动脉瘤相关的SNP(P<0.01):丝氨酸蛋白酶抑制剂1(SERPINE1,P = 0.0008)、转化生长因子β诱导蛋白(TGFBI,P = 0.0026)、基底膜聚糖(HSPG2,P = 0.0044)、纤连蛋白(FN1,P = 0.0069)、原纤蛋白2(FBN2,P = 0.0077)和α1型IV胶原(COL4A1,P = 0.0087)。在310名荷兰白人颅内动脉瘤患者和336名荷兰白人对照者组成的第二个独立队列中,HSPG2基因的关联[合并比值比(OR)1.33,95%置信区间(CI)1.13 - 1.57,P = 6×10⁻⁴]得到了重复验证。该SNP的人群归因风险(PAR)为19%。合并两个队列后,SERPINE1(合并OR 1.27,95% CI 1.07 - 1.50,P = 0.004,PAR 6%)、FBN2(合并OR 1.37,95% CI 1.07 - 1.75,P = 0.01,PAR 3%)和COL4A1(合并OR 1.22,95% CI 1.05 - 1.42,P = 0.007,PAR 7%)基因仍显示出关联。这些PAR可能被高估了,因为它们是根据我们关联研究的第1阶段和第2阶段的联合分析计算得出的。我们的研究结果表明,参与动脉壁ECM完整性维持的基因变异在颅内动脉瘤易感性中起作用。这些发现进一步支持了我们的假设,即动脉壁ECM维持能力下降在颅内动脉瘤的发生发展中很重要。